INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Capital/Financing Update 2025

Apr 22, 2025

April 22, 2025

BSE Limited

The Listing Department Phiroze Jeejeebhoy Towers 25[th] Floor, Dalal Street Fort, Mumbai 400 001 Maharashtra, India

National Stock Exchange of India Limited

The Listing Department Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex Bandra (East), Mumbai 400051 Maharashtra, India

BSE Scrip Code: 544309

NSE Symbol: IKS

Dear Sir/Ma’am,

Subject : Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”) – Further investment in Inventurus Knowledge Solutions, Inc., a wholly owned subsidiary.

Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has made a further investment of USD 14,500,528 in Inventurus Knowledge Solutions, Inc. (“IKS Inc”), a wholly owned subsidiary of the Company.

The relevant disclosure as required under Regulation 30 of the SEBI LODR read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure -I .

Kindly take the above-mentioned information on record.

Thanking you,

Yours sincerely

For Inventurus Knowledge Solutions Limited

Sameer Digitally signed by Sameer Shashikant Shashikant Chavan Chavan Date: 2025.04.22 20:19:15 +05'30' Sameer Chavan

Company Secretary and Compliance Officer

Membership No.: F7211

Enclosure: As above

ANNEXURE – I

DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR READ WITH SEBI MASTER CIRCULAR NO. SEBI/HO/CFD/POD2/CIR/P/0155 DATED NOVEMBER 11, 2024

Sr. No.	Particulars		Details	Details
1.	Name of the target entity, details in brief such as size, turnover etc.		Inventurus Knowledge Solutions Inc. (“IKS Inc.”) is a wholly owned subsidiary of the Company. IKS Inc. is engaged in providing a care enablement platform which comprises of technology enabled solutions for healthcare providers. Financial Details of IKS Inc: Particulars Amt in INR Mn FY 2023-24 Revenue from Operations 7,027.85 Other Income 39.73 Total Income 7,067.58
			Particulars	Amt in INR Mn FY 2023-24
			Revenue from Operations	7,027.85
			Other Income	39.73
			Total Income	7,067.58
2.	Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm’s length"		IKS Inc is a wholly owned subsidiary of the Company and therefore related party, and a transaction is on an arm’s length basis. None of the Company’s promoter / promoter group / group companies have any interest in the said transaction.
3.	Industry to which the entity being acquired belongs		Care enablement platform which comprises of technology enabled solutions for healthcare providers.
4.	Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity)		Working Capital
5	Brief details of any governmental or regulatory approvals required for the acquisition		Not Applicable

				On or before May 31, 2025. Cash Consideration USD 627.81 per share No. of equity shares acquired: 23,097 IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2023-24 FY 2022-23 FY 2021-22 Revenue from operations 7,027.85 6,054.66 4,745.92	On or before May 31, 2025. Cash Consideration USD 627.81 per share No. of equity shares acquired: 23,097 IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2023-24 FY 2022-23 FY 2021-22 Revenue from operations 7,027.85 6,054.66 4,745.92	On or before May 31, 2025. Cash Consideration USD 627.81 per share No. of equity shares acquired: 23,097 IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2023-24 FY 2022-23 FY 2021-22 Revenue from operations 7,027.85 6,054.66 4,745.92	On or before May 31, 2025. Cash Consideration USD 627.81 per share No. of equity shares acquired: 23,097 IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2023-24 FY 2022-23 FY 2021-22 Revenue from operations 7,027.85 6,054.66 4,745.92
	6.	Indicative time period for completion of the acquisition		On or before May 31, 2025.
	7.	Nature of consideration - whether cash consideration or share swap and details of the same		Cash Consideration
	8.	Cost of acquisition or the price at which the shares are acquired		USD 627.81 per share
	9.	Percentage of shareholding / control acquired and / or number of shares acquired.		No. of equity shares acquired: 23,097 IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same.
	10.	Brief background about the entity acquired in terms of products / line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief);		IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2023-24 FY 2022-23 FY 2021-22 Revenue from operations 7,027.85 6,054.66 4,745.92
				Particulars	FY 2023-24	FY 2022-23	FY 2021-22
				Revenue from operations	7,027.85	6,054.66	4,745.92